Glucagone-Like Peptide-1 Receptor Agonists (GLP-1 RAs) (GLP-1RAs) are incretine-based glucose-lowering medications widely used in the treatment of Diabetes Mellitus type 2 (DM2) [9,10]. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.